121 related articles for article (PubMed ID: 3892359)
1. Assessment of the role of "enkephalinase" in cholecystokinin inactivation.
Zuzel KA; Rose C; Schwartz JC
Neuroscience; 1985 May; 15(1):149-58. PubMed ID: 3892359
[TBL] [Abstract][Full Text] [Related]
2. Protection by serine peptidase inhibitors of endogenous cholecystokinin released from brain slices.
Rose C; Camus A; Schwartz JC
Neuroscience; 1989; 29(3):583-94. PubMed ID: 2739903
[TBL] [Abstract][Full Text] [Related]
3. Endopeptidase-24.11 and aminopeptidase activity in brain synaptic membranes are jointly responsible for the hydrolysis of cholecystokinin octapeptide (CCK-8).
Matsas R; Turner AJ; Kenny AJ
FEBS Lett; 1984 Sep; 175(1):124-8. PubMed ID: 6090206
[TBL] [Abstract][Full Text] [Related]
4. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a serine peptidase responsible for the inactivation of endogenous cholecystokinin in human brain.
Rose C; Vargas F; Silhouette B; Devaux B; Schwartz JC
Neuropeptides; 1995 Mar; 28(3):157-60. PubMed ID: 7791959
[TBL] [Abstract][Full Text] [Related]
6. Role of a serine endopeptidase in the hydrolysis of exogenous cholecystokinin by brain slices.
Camus A; Rose C; Schwartz JC
Neuroscience; 1989; 29(3):595-602. PubMed ID: 2662053
[TBL] [Abstract][Full Text] [Related]
7. In vitro degradation of the C-terminal octapeptide of cholecystokinin by 'enkephalinase A'.
Deschodt-Lanckman M; Strosberg AD
FEBS Lett; 1983 Feb; 152(1):109-13. PubMed ID: 6132834
[TBL] [Abstract][Full Text] [Related]
8. Investigation on the metabolism of CCK8 analogues by rat brain slices.
Durieux C; Charpentier B; Pelaprat D; Roques BP
Neuropeptides; 1986 Jan; 7(1):1-9. PubMed ID: 3456492
[TBL] [Abstract][Full Text] [Related]
9. Hydrolysis of the C-terminal octapeptide of cholecystokinin by rat kidney membranes: characterization of the cleavage by solubilized endopeptidase-24.11.
Najdovski T; Collette N; Deschodt-Lanckman M
Life Sci; 1985 Sep; 37(9):827-34. PubMed ID: 3897758
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. III. Inactivation of CCK-8 by a phosphoramidon-sensitive endopeptidase.
Deschodt-Lanckman M; Koulischer D; Przedborski S; Lauwereys M
Peptides; 1984; 5(3):649-51. PubMed ID: 6089150
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of enkephalinase, angiotensin converting enzyme, and a third peptidyldipeptidase from rat brain.
Cushman DW; Gordon EM; Wang FL; Cheung HS; Tung R; Delaney NG
Life Sci; 1983; 33 Suppl 1():25-8. PubMed ID: 6319870
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
[TBL] [Abstract][Full Text] [Related]
13. Release of proenkephalin-derived opioid peptides from rat striatum in vitro and their rapid degradation.
Patey G; Cupo A; Mazarguil H; Morgat JL; Rossier J
Neuroscience; 1985 Aug; 15(4):1035-44. PubMed ID: 4047398
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of enkephalinase B inhibitors, and their activity on isolated enkephalin-degrading enzymes.
Van Amsterdam JG; Van Buuren KJ; Blad MW; Soudijn W
Eur J Pharmacol; 1987 Mar; 135(3):411-8. PubMed ID: 3556201
[TBL] [Abstract][Full Text] [Related]
15. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F
J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of tripeptidyl peptidase II, a cholecystokinin-inactivating enzyme, in rat brain.
Facchinetti P; Rose C; Rostaing P; Triller A; Schwartz JC
Neuroscience; 1999; 88(4):1225-40. PubMed ID: 10336132
[TBL] [Abstract][Full Text] [Related]
17. The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices.
Giros B; Llorens-Cortes C; Gros C; Schwartz JC
Peptides; 1986; 7(4):669-77. PubMed ID: 3532054
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain.
Waksman G; Hamel E; Fournié-Zaluski MC; Roques BP
Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1523-7. PubMed ID: 3006054
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of two probes for the localisation of enkephalinase in rat brain: [3H]thiorphan and a 125I-labeled monoclonal antibody.
Pollard H; De la Baume S; Bouthenet ML; Schwartz JC; Ronco P; Verroust P
Eur J Pharmacol; 1987 Jan; 133(2):155-64. PubMed ID: 3545855
[TBL] [Abstract][Full Text] [Related]
20. CCK26-33 degrading activity in brain and nonneural tissue: a metalloendopeptidase.
Steardo L; Knight M; Tamminga CA; Barone P; Kask AM; Chase TN
J Neurochem; 1985 Sep; 45(3):784-90. PubMed ID: 3897456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
